Robuta

https://www.firmenpresse.de/pressrelease18528/active-biotech-raises-sek-149-million-through-a-directed-share-issue.html Active Biotech raises SEK 149 million through a directed share issue The Board of Directors of Active Biotech has, pursuant to the authorizationgiven by the 2009 annual general meeting, resolved today to issue a tot ... active biotechsekmilliondirectedshare https://www.contractresearchmap.com/providers/active-biotech Active Biotech Locations - Contract Research Map active biotechcontract researchlocationsmap https://www.financialnewsmedia.com/active-biotech-alert-fda-approves-16-new-cancer-treatments-as-global-cancer-rates-skyrocket/ Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket -... Oct 4, 2024 - EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END active biotechcancer treatmentsalertfdaapproves https://www.bmpharmaceuticals.com/active-biotech-fda-grants-orphan-drug-designation-for-tasquinimod-for-the-treatment-of-multiple-myeloma/ Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple... active biotechthe treatmentfdagrantsorphan https://www.evotec.com/news/evotec-and-active-biotech-extend-and-expand-medicinal-chemistry-collaboration Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration - Evotec active biotechmedicinal chemistryevotecextendexpand https://rapidus.se/company/active-biotech/ Active Biotech-arkiv - Rapidus active biotecharkivrapidus https://mfn.se/a/active-biotech/active-biotech-interim-report-q1-2026 MFN.se Active Biotech Active Biotech Interim Report Q1 2026 May 7, 2026 - EVENTS DURING THE FIRST QUARTER The US Patent Office (US PTO) granted a patent related to a pharmaceutical formulation of tasquinimod (January) Active Biotech... active biotechinterim reportmfnse https://www.pharmoutsourcing.com/1315-News/110533-Evotec-and-Active-Biotech-Extend-and-Expand-Medicinal-Chemistry-Collaboration/ Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration | Pharmaceutical... Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration active biotechmedicinal chemistryevotecextendexpand https://www.wellington.com/en-ie/institutional/insights/why-now-for-active-biotech-investing Why now for active biotech investing | Wellington Ireland Institutional Oct 22, 2024 - From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run. why nowactive biotechinvestingwellingtonireland https://www.dcatvci.org/top-industry-news/teva-active-biotech-advance-small-molecule-ms-drug-laquinimod/ Teva, Active Biotech Advance Small-Molecule MS Drug Laquinimod - DCAT Value Chain Insights Sep 8, 2021 - Teva Pharmaceutical Industries Ltd. and Active Biotech, a biopharmaceutical company based in Lund, Sweden, have expanded their clinical development program for... active biotechsmall moleculevalue chaintevaadvance https://www.personalcareinsights.com/news/givaudan-active-beauty-launches-white-biotech-ingredient-neoporyl-to-shrink-enlarged-pores.html Givaudan Active Beauty launches white biotech ingredient Neoporyl to shrink enlarged pores Givaudan is debuting the active ingredient Neoporyl, which reportedly targets the root cause of large pores within one week. active beautyenlarged poresgivaudanlauncheswhite https://www.kennethresearch.com/report-details/global-active-pharmaceutical-ingredients-api-market/10325687 Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech,... Global Active Pharmaceutical Ingredients (API) Market Insights includes market share, market research report, market trade, market prices, market geography... pharmaceutical ingredientsapi marketglobalactivesynthesis